You are here

Advisory Committee on Complementary Medicines (ACCM)

Related information

19 February 2020

Role of the ACCM

The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the Therapeutic Goods Administration (TGA) on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.

The Committee is established under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.

ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.

Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.



Professor Peter Howe is Professor of Nutrition Research at the University of Newcastle and Professor of Clinical Nutrition at the University of Southern Queensland. He is also Adjunct Professor at the University of South Australia and the University of Adelaide. With an extensive track record of multidisciplinary preclinical and clinical research in nutrition, cardiovascular physiology and neuroscience, he has sought to strengthen the evidence base for health benefits of functional foods and nutraceuticals through collaborative partnerships with the industry. Professor Howe has published 250 papers with 6500 citations and is joint Editor-in-chief of the open access journal Nutrients and a Fellow of the Nutrition Society of Australia. Professor Howe provides expertise in the field of nutrition and nutritional medicine.


Mrs Kym Child is currently working for the Tasmanian Office of Ombudsman and Health Complaints Commissioner as a Senior Investigation Officer. She has held a number of positions including as the consumer representative on the Tasmanian Pharmacy Authority and also as a lawyer on the University of Tasmania Human Research and Ethics Committee. She is currently a member of the Tasmanian Mental Health Tribunal. She has previously worked in both the Legal Unit and the Safety and Quality Unit at the Royal Hobart Hospital, as well as being a Senior Regulatory and Policy Officer in the Regulation Unit at the Tasmanian Department of Health. In addition to her legal qualification, Mrs Child is also a Registered Nurse, holding post graduate qualifications in Paediatric Nursing and Emergency Nursing. She continues to work casually after hours as a Hospital Coordinator in the private system. Mrs Child provides expertise in the field of consumer health issues.

Dr Alison Haywood is Senior Lecturer at the School of Pharmacy, Griffith University and an Honorary Senior Research Fellow at Mater Medical Research Institute. Her research interests are in personalised medicine. Her involvement in clinical research includes drug analysis, formulation and stability, pharmacometrics, pharmacogenomics and evidence based medicine. Dr Haywood provides expertise in the field of manufacture of medicines.

Dr Di Wen Lai graduated from Guangzhou University of Traditional Chinese Medicine in 1986 with a Bachelor of Medicine degree. She obtained a Graduate Diploma in Preventative Medicine from Edith Cowan University, WA and studied Medical Laboratory Science at Curtin University, Western Australia. Dr Lai is a registered Chinese Medicine practitioner and has conducted a private practice in Perth since 1990. She was appointed as a practitioner member to the inaugural Chinese Medicine Board of Australia in 2011 by the Australian Health Workforce Ministerial Council. Dr Lai provides expertise in the field of complementary medical practice (Chinese medicine) and naturopathy.

Ms Gwynneth McLeod is a pharmacist with fourteen years of experience in community pharmacy. She is working as a Pharmacist Advisor, Pharmaceutical Benefits Scheme (PBS) Operations and Strategy at the Pharmacy Guild of Australia. Ms McLeod provides expertise in the field of pharmacology.

Professor Kylie O'Brien is an Adjunct Associate Professor at Torrens University, and an Adjunct Fellow of the National Institute of Complementary Medicine Health Research Institute (Western Sydney University). She holds a PhD (Chinese Medicine), B AppSc(Chinese Medicine), MPH, BSc(Optom) and a Grad Cert Tertiary Education. Kylie previously worked for the Victorian Department of Human Services on the implementation of the Chinese Medicine Act 2000 when Chinese medicine was first regulated in Victoria. She is an experienced educator who has previously developed three Master degree courses in Chinese medicine, coordinated undergraduate and postgraduate courses in Chinese medicine, supervised postgraduate research students, and held senior teaching and learning positions in universities and the private tertiary education sector. She has led the development of a Chinese herb-drug interactions database, and is currently involved in research and education in medicinal cannabis. She also practises Chinese medicine part-time. She is a member of the Tertiary Education Quality and Standards Agency (TEQSA) Expert Panel and the World Federation of Chinese Medicine Societies' Specialty Committee for Cancer Rehabilitation. She is also a published book author in the area of integrative oncology. Dr O'Brien provides expertise in the field of herbal medicine and complementary medical practice (Chinese medicine).

Professor David Sibbritt is a Professor of Epidemiology and Deputy Director of the Australian Research Centre in Complementary and Integrative Medicine at University of Technology, Sydney; a world-leading critical public health research centre focusing on complementary and integrative health care. He is an experienced quantitative researcher and has produced over 250 academic publications. Professor Sibritt provides expertise in the field of epidemiology.

Associate Professor Evelin Tiralongo holds dual Australian and German registrations as a pharmacist, with postgraduate degrees in pharmacognosy and biochemistry. She is the Director of Griffith University's Clinical Trial Unit and is also Discipline Head for Complementary Medicine Education in Pharmacy Programs. She has been published widely, serves on several editorial boards and was a member of the National Health and Medical Research Council Homeopathy Working Group. Associate Professor Tiralongo provides expertise in the field of pharmacognosy and biochemistry.

2020 ACCM proposed meeting dates

Meeting no. Meeting dates
24 19 March 2020
25 16 July 2020
26 10 November 2020

Contact details for the ACCM

Phone +61 2 6232 8665
Mobile +61 468 609 842
Fax +61 2 6203 1250
Postal Address Advisory Committee on Complementary Medicines
Therapeutic Goods Administration
PO Box 100
Attn: Scheduling & Committee Support Section, MDP 122